Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds through an initial public offering (IPO). The Gujarat-based company’s proposed IPO comprises fresh issue of equity shares aggregating up to Rs 190 crore and an offer for sale (OFS) of 71.55 lakh equity shares by promoters, according to the draft red herring prospectus (DRHP).
Nithin Kamath slams ‘Dark Patterns’ in finance apps, tells how Zerodha remains clean
Zerodha CEO Nithin Kamath criticized financial apps for using manipulative ‘dark patterns’ that mislead users into actions not in their best interest. He emphasized Zerodha’s